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Background: Prophylactic systemic antibiotics significantly lower the risk of postoperative infection, and injection of
antibiotics directly into the wound cavity has been found to be even more effective. In this study, we investigated the
efficacy of direct injection of antibiotics into a wound cavity after wound closure, both alone and in combination with
systemic administration of antibiotics. We hypothesized that a combination of preoperative systemic administration
and postoperative local injection would be the most effective treatment.
Methods: Rats were divided into six treatment groups: no treatment, local gentamicin, systemic cefazolin, local
cefazolin, systemic cefazolin plus local gentamicin, and systemic cefazolin plus local cefazolin. A wound cavity was
opened along the femur, an implant was placed, and the wound was inoculated with 2.5 · 108 colony forming units of
Staphylococcus aureus. Systemic antibiotics were injected subcutaneously thirty minutes before the initial incision.
Local antibiotics were injected percutaneously into the wound cavity after closure. The rats were killed at forty-eight
hours postoperatively, and quantitative cultures were performed.
Results: All groups that received antibiotics showed significantly lower bacterial counts than the no-treatment control
group (p < 0.0003). Local gentamicin treatment decreased the number of colony-forming-unit isolates by approximately
two orders of magnitude as compared with the number in the group treated with systemic cefazolin (p = 0.00005) and
five orders of magnitude as compared with the number in the control group (p = 0.00003). The combination of systemic
cefazolin and local gentamicin decreased the bacterial count by approximately seven orders of magnitude as compared
with the count in the no-treatment control group and significantly decreased the count as compared with that in the
group treated with local gentamicin alone (p = 0.00006).
Conclusions: As we hypothesized, the combination of systemic cefazolin and local gentamicin proved to be the most
effective regimen. Local injection of gentamicin proved more effective than systemic administration of cefazolin but was
not as effective as the combination of both antibiotics. The initially high concentrations of locally applied antibiotic and
the utilization of two different classes of antibiotics may have contributed to the observed efficacy.
Clinical Relevance: If our findings are supported by those in clinical trials, the combination of local gentamicin and
systemic cefazolin could prove valuable as a regimen for prophylaxis against surgical wound infection.
P
ostoperative infections have been shown to significantly
increase morbidity, extend the patient’s hospital stay, dras-
tically increase the cost to the medical system, and cause
severe physical limitations that diminish quality of life1. Postoper-
ative infection has been estimated to occur following 1% to 2% of
all total hip arthroplasties and 2% to 4% of all total knee arthro-
plasties in the United States2,3. In 2002, more than 193,000 total
hip arthroplasties and 381,000 total knee arthroplasties were per-
formed4. Thus, even with relatively low infection rates, a substantial
number of infections will still occur. With the serious implications
of postoperative infection, it is imperative that measures, including
the use of prophylactic antibiotics, be taken to prevent infection.
Disclosure: In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants of
less than $10,000 from the National Institutes of Health. Neither they nor a member of their immediate families received payments or other benefits or a
commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any
benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a
member of their immediate families, are affiliated or associated.
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Sterile surgical technique and intravenous administra-
tion of antibiotics such as cefazolin, cefuroxime, vancomycin,
or clindamycin prior to incision are the current standard of
care in orthopaedic surgery. However, the prolonged and in-
discriminate use of antimicrobials has been associated with the
emergence of resistant strains of bacteria5-7. Staphylococcus
species are the most important group of bacteria responsible
for postoperative infection, with Staphylococcus aureus and
Staphylococcus epidermidis accounting for 50% to 60% of all
infections contracted during total hip arthroplasties since
19802. An increasing proportion of these infections has been
caused by antimicrobial-resistant strains such as methicillin-
resistant Staphylococcus aureus. Therefore, the development of
a more effective prophylactic regimen to reduce the rate of
emergence of resistant strains would be beneficial.
Various antibiotic delivery methods, such as implant-
able pumps, antibiotic-containing plaster of Paris, antibiotic-
containing bone cement, topical agents, and local administration,
have been developed for the treatment of established infection8-13.
A recent study from our laboratory showed an injection of
gentamicin into the surgical wound cavity after closure of the
incision to be two orders of magnitude more effective than
preoperative systemic administration of antibiotics for reducing
in-wound bacterial counts two days postoperatively11. Thus, the
local administration of gentamicin for prophylaxis against sur-
gical wound infection is promising, but to our knowledge it has
not been compared with the administration of other antibiotics
locally or with combinations of local and systemic antibiotics14,15.
One benefit of local administration is that the antibiotic
is delivered directly to the wound cavity rather than diffusing
into the cavity from the bloodstream as occurs with systemic
administration. Another advantage is the ability to obtain a
high antibiotic concentration within the wound cavity while
maintaining safe systemic levels. In many cases, at this high
concentration, bacteria that are normally considered resistant
to an antibiotic fall within its spectrum of effective activity16.
However, care must be taken to avoid excessively high local
concentrations as some antibiotics have demonstrated cyto-
toxicity at very high concentrations, which may inhibit new
bone growth and fracture union17-19.
We hypothesized that a combined treatment consisting of
preoperative systemic and postoperative local antibiotics would
prove more effective than administering antibiotics by either
route alone for prophylaxis against wound infection. We also
hypothesized that using two different classes of antibiotics for
local and systemic administration would prove more effective
than administering only a single class. We selected gentamicin
because it has been proven to be effective in previous studies and
it demonstrates good activity against Staphylococcus aureus11.
We selected cefazolin because it is routinely used for prophy-
laxis in humans and it has also shown good activity against
Staphylococcus aureus. The synergistic action of the amino-
glycoside and cephalosporin classes of antibiotics has been
well documented for many years, and many experiments have
demonstrated improvement in the efficacy of gentamicin when
it is combined with cephalosporin antibiotics20. We did not
include a group treated with systemically administered gen-
tamicin because gentamicin is not routinely given systemically
for prophylaxis before orthopaedic procedures as it is associ-
ated with severe side effects, including ototoxicity and renal
toxicity in up to a third of patients21. Also, we previously per-
formed a study in which local gentamicin proved to be more
effective than systemic gentamicin11.
Materials and Methods
Bacterial Preparation
Staphylococcus aureus (American Type Culture Collection[ATCC] number 25923) was grown in trypticase soy broth
(BD Diagnostics, Sparks, Maryland) at 37C for seventy-two
hours. This strain is susceptible to both gentamicin and ce-
fazolin. The broth was then separated into 1-mL aliquots and
stored in a freezer at a temperature of 280C. A series of 1:10
serial dilutions was then performed on four thawed samples;
the solutions were plated on trypticase soy media and dem-
onstrated an average viable concentration of 5.0 · 108 colony
forming units (CFUs)/mL.
Study Design
After approval of the protocol by our institutional animal care
and use committee, female Sprague-Dawley retired breeder
rats weighing between 250 and 400 g were obtained from a
commercial breeder. Animal selection was randomized, and
antibiotic administration was blinded. The surgical procedure
that was used in the animals was demonstrated to be effective
in producing substantial and consistent wound infection in a
previous study11, and therefore no pilot study was undertaken.
Our study consisted of six different treatment groups with ten
or more rats each (described below).
Surgical Procedure
Cefazolin and gentamicin were obtained from the distributors
and diluted to the appropriate concentrations with use of 0.9%
sterile saline-solution irrigant. The cefazolin was diluted to a
concentration of 7.0 mg/mL for local administration and 50
mg/mL for systemic administration. The gentamicin was di-
luted to 2.0 mg/mL for local administration. The systemic ad-
ministration of cefazolin consisted of a subcutaneous injection
of 1 mL of 50 mg/mL cefazolin above the right thigh thirty
minutes prior to the incision. Isoflurane anesthesia (2% to 3%
to effect) was then administered until the toe pinch reflex was
absent. Electric clippers were used to depilate the lateral portion
of the left thigh. The wound site was prepared with an iodine-
povidone swab, an alcohol swab, and a final iodine-povidone
swab. A 12-mm incision was made along the length of the femur
with scissors. A number-10 scalpel blade was then used to
puncture the fascia. Blunt dissection through the quadriceps
was used to expose the femur, and then a 1.5 · 1.5 · 1.5-cm
wound cavity was created by spreading anteriorly and posteri-
orly along the length of the femur, with a final spread perpen-
dicular to the femur. A 30-gauge stainless-steel suture wire was
placed as a cerclage around the femur at approximately the
midpart of the shaft to simulate an orthopaedic implant. A 0.5-
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mL aliquot of 5.0 · 108 CFUs/mL gentamicin-sensitive Staph-
ylococcus aureus was then pipetted into the wound cavity and
allowed to remain there for 2.5 minutes. The wound was then
irrigated with 0.5 mL of sterile saline solution, and the irrigant
was allowed to run out of the wound. The wound was closed
superficially only with stainless-steel surgical skin clips. After
wound closure, the rats that were to receive local antibiotics
had a needle inserted percutaneously down to the femur to be
sure that it was within the wound cavity and were given an
injection of 1 mL of either 2 mg/mL gentamicin or 7 mg/mL
cefazolin depending on the treatment group. Postoperatively,
rats were given an acetaminophen elixir (6 mg/mL of their
drinking water) for pain control until they were killed.
There were six experimental groups: (1) no treatment
(negative control), in which eleven rats were given neither
systemic nor local antibiotics; (2) local gentamicin (positive
control), in which thirteen rats were given a local injection of
gentamicin (1 mL of a 2.0 mg/mL concentration) into the
wound cavity after closure of the incision; (3) systemic cefaz-
olin, in which ten rats were given a subcutaneous injection of
cefazolin (1 mL of a 50 mg/mL concentration) thirty minutes
preoperatively; (4) local cefazolin, in which thirteen rats were
given a local injection of cefazolin (1 mL of a 7.0 mg/mL
concentration) into the wound cavity after closure of the in-
cision; (5) systemic cefazolin and local gentamicin, in which
fourteen rats were given a subcutaneous injection of cefazolin
(1 mL of a 50 mg/mL concentration) thirty minutes preop-
eratively and a local injection of gentamicin (1 mL of a 2.0 mg/
mL concentration) into the wound cavity after closure of the
incision; and (6) systemic cefazolin and local cefazolin, in
which twelve rats were given a subcutaneous injection of ce-
fazolin (1 mL of a 50 mg/mL concentration) thirty minutes
preoperatively and a local injection of cefazolin (1 mL of a 7.0
mg/mL concentration) into the wound cavity after closure of
the incision.
Outcome Measurement
Two days postoperatively, the rats were killed with a CO2
overdose. The incision site was then prepared with an alcohol
swab to prevent contamination from the skin flora. The wound
clips were removed, and the incision was reopened. Sterile
hemostats were used to spread open the wound cavity, and a
cotton-tipped swab was then passed throughout the cavity for
five seconds. An attempt was made to establish uniform con-
tact with all surfaces within the surgical pocket. The swab was
then placed in a 10-mL centrifuge tube containing 1 mL of
trypticase soy broth and vortexed on a setting of 10 for five
seconds. A series of 1:10 dilutions was performed, and the
diluents were plated on trypticase soy media and then spread
with use of a bent glass Pasteur pipette. The plates were in-
cubated at 37C for twenty-four hours, after which time the
number of CFUs was counted. Only plates containing between
Fig. 1
The mean CFU counts for each treatment group displayed on a logarithmic scale with standard error bars. All
groups treated with antibiotics showed a significant decrease relative to the control group (p < 0.0003). The
number of bacteria in the local gentamicin group was significantly lower than that in the systemic cefazolin group
(p = 0.00005), and the number in the group treated with systemic cefazolin plus local gentamicin was significantly
less than that in the local gentamicin group (p = 0.00006).
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ten and 200 colonies were considered valid. If more than one
plate in each series had a countable number of colonies, the
average was calculated. If either no difference or a difference of
greater than two orders of magnitude was observed between
one serial dilution and the next, the data were discarded, as
such findings were interpreted as representing methodological
error.
Statistical Analysis
The data and therefore the variances were logarithmic as a result
of the nature of microbiological studies. Thus, the Mann-
Whitney U test, a nonparametric method of analysis that
does not assume homoscedasticity, was chosen for statistical
analysis.
Source of Funding
The funding for this project was provided by the University of
North Carolina orthopaedic department and a summer stu-
dent research stipend ($2000) was received from the National
Institutes of Health.
Results
Although the control rats demonstrated marked lethargyand a decreased capacity for movement, all rats survived
the two-day postoperative period and were killed at forty-eight
hours after the initial surgery. Figure 1 displays, on a loga-
rithmic scale, the mean number of CFUs cultured from each of
the six treatment groups. All groups treated with antibiotics
showed a significant decrease (p < 0.0003) in the mean bac-
terial count when compared with the control group (5.80 · 107
CFUs). No significant difference (p = 0.16) was demonstrated
between the group treated with systemic cefazolin (3.30 · 105
CFUs) and the group treated with local cefazolin (2.06 · 105
CFUs). There was a significant difference (p = 0.00005) be-
tween the group treated with systemic cefazolin and that
treated with local gentamicin (9.81 · 102 CFUs). There also
was a significant difference (p = 0.00006) between the group
treated with local gentamicin and that treated with systemic
cefazolin plus local gentamicin (7.41 CFUs). Only a single
wound showed growth (100 CFUs) in the group treated with
systemic cefazolin plus local gentamicin; the rest of the wounds
were sterile.
Discussion
The combination of systemic cefazolin and local gentamicindecreased the bacterial count by approximately seven
orders of magnitude compared with the count in the no-
treatment control group (p = 0.000005). As we hypothesized,
the combination of systemic cefazolin and local gentamicin
was the most effective treatment, with a decrease in the bac-
terial count within the wound by approximately two orders of
magnitude as compared with the count associated with the
next most effective treatment (local gentamicin alone) (p =
0.00006). Local gentamicin treatment decreased CFU isolates
by approximately two orders of magnitude as compared with
that following treatment with systemic cefazolin (p = 0.00005)
and five orders of magnitude as compared with the control
value (p = 0.00003). A significant difference was not demon-
strated between the systemic cefazolin and local cefazolin
groups (p = 0.16), but it should be noted that the dosage of
systemic cefazolin was 100 mg/kg whereas the dosage of local
cefazolin was 14 mg/kg.
In a previous study conducted in our laboratory, similar
methodology was used to investigate local gentamicin antibi-
otic prophylaxis after inoculation of the wound cavity with
8.0 · 105 CFUs of Staphylococcus aureus11. In the current study,
the surgical wound cavity was inoculated with a much greater
bacterial concentration (2.5 · 108 CFUs), and the no-treatment
control group demonstrated a much higher bacterial count
(5.80 · 107 CFUs in this study compared with approximately
3.0 · 105 CFUs in the previous study). In the previous study, we
found that a local gentamicin injection after wound closure
decreased the in-wound bacterial number by nearly five orders
of magnitude compared with the value in the no-treatment
control group, a finding that is similar to the improvement in
the present study.
The particular strain of Staphylococcus aureus that we
used in this study has been used by other investigators as an
example of a methicillin-sensitive Staphylococcus aureus, and
different results would be likely if a methicillin-resistant strain
were employed. The methicillin-sensitive Staphylococcus aureus
that we used is a virulent organism as indicated in our previous
study, in which many of the untreated control animals died
prior to the forty-eight-hour experimental end point11. None
of the control rats died in this study; however, they all appeared
moribund before they were killed.
The current standard of care for prophylaxis for human
patients being treated with an orthopaedic surgical proce-
dure is a preoperative 1-g dose of a cephalosporin antibiotic,
typically cefazolin. Such systemically administered antibiotics
penetrate perfused capillary beds well and diffuse from them
into the wound cavity in low concentrations. Thus, the he-
matoma that forms in the wound contains some antibiotic.
The dosage of systemic cefazolin (approximately 100 mg/kg)
used in this study is based on the finding, in studies of rats, that
such a dose simulates the human serum pharmacokinetics
associated with the 1-g intravenous bolus typically given to
humans as preoperative prophylaxis22. Some surgeons use anti-
biotic irrigants during the procedure, but they are typically
evacuated by surgical suction prior to wound closure and the
duration of bacterial exposure to these antibiotics is short. The
findings in the present study support the administration of a
local antibiotic directly into the wound cavity after closure of
the wound, thus ensuring that the antibiotic reaches the site of
potential infection in a high concentration and is not removed
except by diffusion. Furthermore, with these high antibiotic
concentrations, organisms that are normally considered to be
resistant to the antibiotic could fall within the spectrum of
activity16. It has been shown that local administration results in
high antibiotic concentrations within the wound cavity while
still maintaining safe systemic concentrations. Studies have
demonstrated that locally applied vancomycin can reach levels
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twenty times toxic serum levels while maintaining a safe sys-
temic concentration23. However, there is concern that the ex-
tremely high concentrations that can be reached during local
application of antibiotics can result in local cytotoxic effects on
human cells. The inhibitory effects of antibiotics on osteoblast
or osteoblast-like cell lines have been investigated in various
studies. Isefuku et al. found that gentamicin decreases oste-
oblast metabolism at concentrations above 100 mg/mL and
inhibits cell replication at levels above 700 mg/mL24. The esti-
mated volume of the wound cavity in our study was approx-
imately 3.38 cm3, and 2.0 mg of gentamicin was injected. This
would result in an approximate concentration of 600 mg/mL
in the wound cavity, a level that is below the replication
threshold established by Isefuku et al. Edin et al. determined
that osteoblast replication drops off at a cefazolin concentra-
tion of 1000 mg/mL and death occurs at concentrations higher
than 10,000 mg/mL17. We selected a locally applied dose that
yields an estimated wound concentration of approximately
2100 mg/mL.
In the in vitro studies discussed above, the antibiotic
concentrations on tissue-cultured osteoblasts were maintained
for days. We expect that a single local injection would result in
an initially high local concentration but this concentration
would drop rapidly as the antibiotic is absorbed into the sys-
temic circulation. This rapid drop in local concentration was
demonstrated by Humphrey et al., who implanted a bovine
collagen sponge containing 3 mg/kg of gentamicin (12 mg in a
4-kg rabbit) into a 2 · 2-cm wound in rabbits23. The local
gentamicin level was measured to be 600 mg/mL at four hours
and <7 mg/mL at twenty-four hours. Thus, any toxic effects of
locally applied antibiotics may be transient, especially without
a sustained-release local delivery vehicle. Antibiotic-containing
bone cement is frequently used for prophylaxis for patients
undergoing total knee or total hip arthroplasty. Since such
‘‘depot’’ administration would result in sustained high levels of
antibiotic, it would be better to seek levels well below the
locally toxic concentrations with such methodology. In our
previous study of local antibiotic prophylaxis, we evaluated the
use of powdered plaster of Paris as a material that could be
implanted in surgical wounds, would elute local antibiotics
over a few days, and (unlike acrylic) would not need to be
removed from a patient treated with non-joint-replacement
surgery11. Although the elution from plaster of Paris was ef-
fective, it was not as effective as the simple injection of aqueous
gentamicin; thus, we are no longer pursuing that avenue.
It must be noted that local administration of antibiotics
does not have the same predictability of distribution as a
systemic dose, as some antibiotic may leak from the surgical
field when the closure is not watertight. However, it was quite
effective in this study even if some antibiotic may have been
lost.
Limitations of this study include the low volume of
surgical irrigation that we used. We chose to irrigate the wound
with only 0.5 mL of 0.9% sterile saline solution because this
volume was shown to allow consistent establishment of in-
fection in our previous study11. We recognize, however, that
adequate irrigation with larger volumes than we used should
remain an important infection-control measure and plays a
crucial role in surgical prophylaxis against wound infection.
Furthermore, we investigated only a single species of bacteria
and only two types of antibiotics. These antibiotics were quite
successful in this model but might not be as effective with a
different type of bacterial contamination or in humans. Also,
we administered the cefazolin through a subcutaneous route
for ease of treatment, but there are little data demonstrating
the kinetics of cefazolin distribution after various routes of
administration in rats. Additionally, we did not include an
experimental group treated with systemic gentamicin, so we
could not compare locally administered gentamicin with sys-
temic gentamicin. The inclusion of a group treated with sys-
temic gentamicin could potentially yield information on the
mechanism of bacterial killing, but we did not include such a
group in the present experiment as systemic gentamicin is not
routinely used for orthopaedic prophylaxis because of toxicity.
We demonstrated in a previous study that locally applied
gentamicin performed better than systemically applied genta-
micin, with a decrease in bacterial counts in wound cultures by
more than two orders of magnitude11.
The results of this investigation will need to be con-
firmed in human studies. The strengths of this study include
the control of a number of variables and the evaluation of the
ability of these antibiotics to prevent infection despite very
heavy contamination of the wound with bacteria, features not
possible in a human study. n
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